Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Johnstone

Showing results (81-90 of 352) with videos related to

Pageof 36
Sort By:
British Medical Journal|July 31, 1971
Halothane hepatitisT H Burns, M E Dodson, M W Johnstone
Trends in Biochemical Sciences|January 19, 2000
Multiple physiological functions for multidrug transporter P-glycoprotein?R W Johnstone, A A Ruefli, M J Smyth
The Journal of Biological Chemistry|July 7, 2000
Identification, cloning, expression, and biochemical characterization of the testis-specific RNA polymerase II elongation factor ELL3T Miller, K Williams, R W Johnstone, et al.
Current Cancer Drug Targets|December 10, 2002
Identifying molecular targets mediating the anticancer activity of histone deacetylase inhibitors: a work in progressB G Gabrielli, R W Johnstone, N A Saunders
Oncoimmunology|April 5, 2014
The anticancer effects of HDAC inhibitors require the immune systemAlison C West, Mark J Smyth, Ricky W Johnstone
Applied Optics|March 8, 2008
Mode-hop-free single-longitudinal-mode erbium-doped fiber laser frequency scanned with a fiber ring resonatorS K Kim, G Stewart, W Johnstone, et al.
Cell|February 8, 2002
Apoptosis: a link between cancer genetics and chemotherapyRicky W Johnstone, Astrid A Ruefli, Scott W Lowe
Expert Opinion on Investigational Drugs|April 28, 2007
Histone deacetylase inhibitors in cancer therapyWalid K Rasheed, Ricky W Johnstone, H Miles Prince
The Journal of Biological Chemistry|June 27, 1998
The human interferon-inducible protein, IFI 16, is a repressor of transcriptionR W Johnstone, J A Kerry, J A Trapani
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 13, 2002
Mechanisms of interferon mediated anti-viral resistanceC J Clarke, J A Trapani, R W Johnstone
Pageof 36

Showing results (81-90 of 352) with videos related to

Sort By:
Pageof 36
British Medical Journal|July 31, 1971
Halothane hepatitisT H Burns, M E Dodson, M W Johnstone
Trends in Biochemical Sciences|January 19, 2000
Multiple physiological functions for multidrug transporter P-glycoprotein?R W Johnstone, A A Ruefli, M J Smyth
The Journal of Biological Chemistry|July 7, 2000
Identification, cloning, expression, and biochemical characterization of the testis-specific RNA polymerase II elongation factor ELL3T Miller, K Williams, R W Johnstone, et al.
Current Cancer Drug Targets|December 10, 2002
Identifying molecular targets mediating the anticancer activity of histone deacetylase inhibitors: a work in progressB G Gabrielli, R W Johnstone, N A Saunders
Oncoimmunology|April 5, 2014
The anticancer effects of HDAC inhibitors require the immune systemAlison C West, Mark J Smyth, Ricky W Johnstone
Applied Optics|March 8, 2008
Mode-hop-free single-longitudinal-mode erbium-doped fiber laser frequency scanned with a fiber ring resonatorS K Kim, G Stewart, W Johnstone, et al.
Cell|February 8, 2002
Apoptosis: a link between cancer genetics and chemotherapyRicky W Johnstone, Astrid A Ruefli, Scott W Lowe
Expert Opinion on Investigational Drugs|April 28, 2007
Histone deacetylase inhibitors in cancer therapyWalid K Rasheed, Ricky W Johnstone, H Miles Prince
The Journal of Biological Chemistry|June 27, 1998
The human interferon-inducible protein, IFI 16, is a repressor of transcriptionR W Johnstone, J A Kerry, J A Trapani
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 13, 2002
Mechanisms of interferon mediated anti-viral resistanceC J Clarke, J A Trapani, R W Johnstone
Pageof 36